WATCH: Democrats chant ‘HR 3,’ the drug costs act that died in Senate
"H.R. 3! H.R. 3!" chanted Democrats, jumping to their feet Tuesday night, holding up three fingers.
Watch 3:29
News Wrap: Appeals court strikes down ACA individual mandate
In our news wrap Wednesday, a federal appeals court struck down part of the Affordable Care Act but stopped short of throwing out the entire law. The three-judge panel agreed with a lower court that the individual mandate to buy…
WATCH: Pelosi unveils legislation to reduce Medicare prescription drug prices
The proposal would direct Medicare to negotiate prices for seniors and younger people.
3 problems that are spiking health care costs, according to this surgeon
In his new book, Dr. Marty Makary laments that many of his colleagues have abandoned the Hippocratic Oath in favor of charging inflated prices for surgeries and health procedures that are not in their patients’ best interests.
The move would reverse years of opposition from federal health authorities amid a public outcry over high prices for life-sustaining medications.
The hearing on Capitol Hill comes at a time when the Trump administration has made a push to reduce drug prices and the cost of healthcare overall.
The bill would for the first time limit drug copays for people with Medicare's "Part D" prescription plan, by capping patients' out-of-pocket costs at $3,100 a year starting in 2022.
Drugmakers had argued that requiring them to disclose list prices amounted to coercion that would violate their free speech rights under the Constitution.
Senior lawmakers of both parties proposed legislation to tackle surprise medical bills, prescription drug costs and uneven vaccination rates.
Additional Support Provided By:
